- Home
- » Tags
- » Vasodilatory shock
Top View
- Angiotensin II for Vasodilatory Shock: Is It Ready for Prime Time?
- Pediatric Sepsis Definition—A Systematic Review
- A Systematic Review of Neuroprotective Strategies During Hypovolemia and Hemorrhagic Shock
- Vasopressin in Vasodilatory Shock
- Definitions and Pathophysiology of Vasoplegic Shock Simon Lambden1,2, Ben C
- Vasopressor-Sparing Strategies in Patients with Shock: a Scoping-Review and an Evidence-Based Strategy Proposition
- Role of Vasopressin in Current Anesthetic Practice
- Diagnosis and Management of Shock in the Emergency Department
- Vasopressors and Inotropes in Shock 2019
- Circulatory Shock and Peripheral Circulatory Failure: a Historical Perspective
- PEDIATRIC CARDIOPULMONARY CARE a Heritage of Developing Leading Solutions That Advance the Care and Treatment of the Critically Ill
- Copeptin in Critically Ill Paediatric and Neonatal Intensive Care Patients
- Refractory Vasodilatory Shock Induced by Irbesartan's Acute
- Bench-To-Bedside Review: Oxygen Debt and Its Metabolic Correlates As Quantifiers of the Severity of Hemorrhagic and Post- Trauma
- Postgraduate Education Corner CONTEMPORARY REVIEWS in CRITICAL CARE MEDICINE Early Management of Severe Sepsis
- Shock: Pathophysiology, Diagnosis, 1 Treatment, and Physiologic Response to Trauma Katharyn Mitchell and Angelika Schoster
- Vasoplegia Treatments: the Past, the Present, and the Future
- Refractory Septic Shock: Our Pragmatic Approach Prashanth Nandhabalan* , Nicholas Ioannou, Christopher Meadows and Duncan Wyncoll
- Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
- Intensive Care Management of Acute Liver Failure Georg Auzinger and Julia Wendon
- Cardiovascular System (3-30-2020)
- Inotropes, Absolute Monocyte Counts and Survival of Children with Septic Shock
- Angiotensin II Use in Refractory Multisystem Shock: a Case Report
- Vasopressor Therapy in Critically Ill Patients with Shock James A
- Acute Liver Failure
- FY20 Publications